Literature DB >> 7138063

Developmental and neurological progress of preterm infants with intraventricular haemorrhage and ventricular dilatation.

P Palmer, L M Dubowitz, M I Levene, V Dubowitz.   

Abstract

A prospective neurological and developmental assessment was completed at ages 6, 9, and 12 months on 39 preterm infants under 34 weeks' gestation. In the newborn period each infant had an assessment of gestation and sequential neurological and ultrasound examinations and was placed in one of three groups: intraventricular haemorrhage (IVH) (n = 14), IVH followed by ventricular dilatation (n = 11), and control infants with no evidence of IVH (n = 14). When corrected for prematurity the Griffiths's developmental quotients (DQs) were normal at 6, 9, and 12 months for every infant except one aged 12 months. In contrast, the uncorrected DQs at 12 months were under 80 in only one of the 14 preterm infants without haemorrhage, compared with 2 of the 14 with IVH, and with 7 of the 9 with IVH and dilatation. There was also a higher incidence of neurological abnormality at each follow-up age in the infants with IVH plus ventricular dilatation, compared with those with IVH alone, or with infants without IVH. Similar differences were also demonstrated in 5 milestones reflecting gross motor, fine motor, and social or verbal development in the three groups at 6, 9, and 12 months. The neurological and developmental deficits seemed to relate more closely to the presence of post-haemorrhagic ventricular dilatation than to the size of the initial haemorrhage itself. These results may have important implications for therapeutic intervention in the management of newborn infants with IVH and ventricular dilatation.

Entities:  

Mesh:

Year:  1982        PMID: 7138063      PMCID: PMC1627927          DOI: 10.1136/adc.57.10.748

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.

Authors:  L A Papile; J Burstein; R Burstein; H Koffler
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

2.  Infantile hydrocephalus: clinical, histological, and ultrastructural study of brain damage.

Authors:  R O Weller; K Shulman
Journal:  J Neurosurg       Date:  1972-03       Impact factor: 5.115

3.  Clinical assessment of gestational age in the newborn infant.

Authors:  L M Dubowitz; V Dubowitz; C Goldberg
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

4.  Prediction of death and major handicap in very preterm infants by brain ultrasound.

Authors:  R J Thorburn; A P Lipscomb; A L Stewart; E O Reynolds; P L Hope; K E Pape
Journal:  Lancet       Date:  1981-05-23       Impact factor: 79.321

5.  Risk factors in the development of intraventricular haemorrhage in the preterm neonate.

Authors:  M I Levene; C L Fawer; R F Lamont
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

6.  Measurement of the growth of the lateral ventricles in preterm infants with real-time ultrasound.

Authors:  M I Levene
Journal:  Arch Dis Child       Date:  1981-12       Impact factor: 3.791

7.  A longitudinal study of post-haemorrhagic ventricular dilatation in the newborn.

Authors:  M I Levene; D R Starte
Journal:  Arch Dis Child       Date:  1981-12       Impact factor: 3.791

8.  Cerebral structure and intraventricular haemorrhage in the neonate: a real-time ultrasound study.

Authors:  M I Levene; J S Wigglesworth; V Dubowitz
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

9.  Neurologic sequelae in the survivors of neonatal intraventricular hemorrhage.

Authors:  K S Krishnamoorthy; D C Shannon; G R DeLong; I D Todres; K R Davis
Journal:  Pediatrics       Date:  1979-08       Impact factor: 7.124

  9 in total
  17 in total

1.  Area of lateral ventricles measured on cranial ultrasonography in preterm infants: association with outcome.

Authors:  E Saliba; P Bertrand; F Gold; S Marchand; J Laugier
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.

Authors:  J Schulte; J Osborne; J W T Benson; R Cooke; M Drayton; J Murphy; J Rennie; B Speidel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

3.  Abnormal Ventricular Development in Preterm Neonates with Visually Normal MRIs.

Authors:  Jie Shi; Yalin Wang; Yi Lao; Rafael Ceschin; Liang Mi; Marvin D Nelson; Ashok Panigrahy; Natasha Leporé
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-11-22

4.  Effect of neonatal periventricular haemorrhage on neurodevelopmental outcome.

Authors:  A G Catto-Smith; V Y Yu; B Bajuk; A A Orgill; J Astbury
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

5.  Denver developmental screening test and preterm infants.

Authors:  A M Elliman; E M Bryan; A D Elliman; P Palmer; L Dubowitz
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

6.  Early and late cranial ultrasonographic appearances and outcome in very low birthweight infants.

Authors:  R W Cooke
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

7.  Value of cranial ultrasound in newborn baby.

Authors:  S Sinha; M Chiswick
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

8.  Frequency and prognostic significance of germinal matrix hemorrhage, periventricular leukomalacia, and pontosubicular necrosis in preterm neonates.

Authors:  K Skullerud; B Westre
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  '....officiously to keep alive'.

Authors:  C H Walker
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

10.  Head size, brain growth, and lateral ventricles in very low birthweight infants.

Authors:  S W D'Souza; M Gowland; B Richards; J Cadman; V Mellor; D G Sims; M L Chiswick
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.